HomeSENORES • NSE
add
Senores Pharmaceuticals Ltd
Previous close
₹464.75
Day range
₹460.50 - ₹497.70
Year range
₹435.25 - ₹609.65
Market cap
21.68B INR
Avg Volume
905.88K
P/E ratio
49.94
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 905.09M | — |
Operating expense | 293.73M | — |
Net income | 117.74M | — |
Net profit margin | 13.01 | — |
Earnings per share | — | — |
EBITDA | 212.48M | — |
Effective tax rate | 18.57% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 139.26M | — |
Total assets | 6.78B | — |
Total liabilities | 3.59B | — |
Total equity | 3.19B | — |
Shares outstanding | 46.05M | — |
Price to book | 5.30 | — |
Return on assets | 6.85% | — |
Return on capital | 8.15% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 117.74M | — |
Cash from operations | 31.93M | — |
Cash from investing | -272.33M | — |
Cash from financing | 244.76M | — |
Net change in cash | 4.36M | — |
Free cash flow | -148.70M | — |
About
Founded
2017
Website
Employees
145
